Market Research Logo

European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

European Market Report for Peripheral Intravenous Catheters 2017 - MedCore

The European PIVC market includes three segments: conventional PIVCs, safety PIVCs and midlines. The safety PIVC segment includes three sub-segments: active safety PIVCs, passive safety PIVCs and closed system PIVCs. The midline market comprises three sub-segments: conventional midlines, power-injectable midlines and all-in-one midlines. The PIVC markets in Europe were transformed in 2013 following the implementation of the directive by the Council of the European Union which aims to prevent needlestick injuries to healthcare workers. EU legislation as well as national legislation has put in place significant penalties for facilities that have a high incidence of needlestick injuries. To avoid the legal and health risks hospitals have been transitioning to the use of safety PIVCs. As a result, the conventional PIVC market will continue to decline over the forecast period. The value of the midline market is expected to increase strongly over the forecast period as adoption increases. The European peripheral intravenous catheters PIVC market includes three segments: conventional PIVCs, safety PIVCs and midlines. The safety PIVC segment includes three sub-segments: active safety PIVCs, passive safety PIVCs and closed system PIVCs. The midline market comprises three sub-segments: conventional midlines, power-injectable midlines and all-in-one midlines.

Peripheral intravenous catheters (PIVCs), also known as short peripheral IV catheters, are the most commonly used type of vascular access catheters. Almost 90% of patients admitted to hospitals receive a vascular access device, the vast majority of which are PIVCs. These devices are intended for short-term use, usually no longer than three days, and are inserted into the median cubital vein or the forearm extending for only a few inches. Owing to their peripheral placement, these catheters cannot be used for infusing toxic, irritating or vesicant drugs, including most of those used for chemotherapy. The flow rates of PIVCs are lower than central line catheters, such as central venous catheters (CVCs), making them best suited for blood sampling and infusing fluids and medicine.


EXECUTIVE SUMMARY
EUROPEAN MARKET FOR VASCULAR ACCESS DEVICES AND ACCESSORIES OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Human Vascular System
2.2 VASCULAR PATHOLOGY AND DISORDERS
2.2.1 Cancer
2.2.2 End-Stage Renal Disease
2.2.3 Diabetes
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Peripheral Intravenous Catheters
3.1.1.1 Introduction
3.1.1.2 Access Scientific
3.1.1.2.1 POWERWAND®
3.1.1.3 AngioDynamics
3.1.1.3.1 BioFlo®
3.1.1.4 Argon Medical
3.1.1.4.1 First Midcath™
3.1.1.4.2 L-Cath™
3.1.1.5 B. Braun
3.1.1.5.1 Introcan Safety®
3.1.1.6 Becton Dickinson
3.1.1.6.1 Nexiva™
3.1.1.6.2 Saf-T-Intima™
3.1.1.6.3 Autoguard™
3.1.1.7 C.R. Bard
3.1.1.7.1 AccuCath®
3.1.1.7.2 PowerGlide®
3.1.1.7.3 Bard® Poly
3.1.1.7.4 Other Midline Offerings
3.1.1.8 GaltNeedleTech
3.1.1.8.1 Nexus™
3.1.1.9 Medcomp
3.1.1.9.1 Medcomp® Midline
3.1.1.10 MediKit
3.1.1.10.1 Supercath™
3.1.1.11 Neo Medical
3.1.1.11.1 PowerStick™
3.1.1.11.2 Neo-Magic®
3.1.1.12 Nipro Medical
3.1.1.12.1 Nipro™ IV Catheter
3.1.1.13 Retractable Technologies, Inc.
3.1.1.13.1 VanishPoint®
3.1.1.14 Smiths Medical
3.1.1.14.1 ViaValve™
3.1.1.14.2 PROTECTIV®
3.1.1.14.3 ACUVANCE®
3.1.1.14.4 Other PIVC offerings
3.1.1.15 Tangent Medical
3.1.1.15.1 NovaCath™
3.1.1.16 Teleflex Medical
3.1.1.16.1 ARROW®
3.1.1.16.2 TwinCath®
3.1.1.17 Terumo
3.1.1.17.1 SurFlash®
3.1.1.17.2 SURFLO®
3.1.1.18 Vygon
3.1.1.18.1 Leader-Flex™
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 November 2015
3.2.2 October 2015
3.2.3 September 2015
3.2.4 August 2015
3.2.5 July 2015
3.2.6 April 2015
3.2.7 March 2015
3.2.8 February 2015
3.2.9 January 2015
3.2.10 December 2014
3.2.11 October 2014
3.2.12 September 2014
3.2.13 May 2014
3.2.14 April 2014
3.2.15 March 2014
3.2.16 January 2014
3.2.17 December 2013
3.2.18 September 2013
3.2.19 August 2013
3.2.20 June 2013
3.2.21 March 2013
3.2.22 February 2013
3.2.23 December 2012
3.2.24 August 2012
3.2.25 June 2012
3.2.26 May 2012
3.2.27 March 2012
3.2.28 February 2012
3.2.29 January 2012
3.3 CLINICAL TRIALS
3.3.1 Peripheral Intravenous Catheters
3.4 PRODUCT PIPELINES
3.4.1 Alliance Vascular Devices, LLC
3.4.1.1 FreeHand Safety Huber Needle®
3.4.2 AngioDynamics
3.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation
3.4.2.2 Firefly
3.4.2.3 BioFlo® PICC Line Extension
3.4.2.4 BioFlo® Port Line Extension
3.4.2.5 Next Generation BioFlo® PICC
3.4.2.6 Next Generation BioFlo® Port
3.4.3 Bluegrass Vascular Technologies, Inc.
3.4.3.1 Surfacer® Inside-Out™ Access System
3.4.4 C.R. Bard
3.4.4.1 Chemical-Resistant PICCs
3.4.4.2 Novel Advanced Material PICCs
3.4.4.3 PowerGlide® Pro Midline
3.4.4.4 AccuCath®
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter
3.4.4.6 Site~Rite® 8 Ultrasound System
3.4.5 M. C. Johnson
3.4.5.1 PICC Securement Device
3.4.6 Nipro Medical
3.4.6.1 Shielding Safety Needle
3.4.6.2 Safety Syringe
3.4.6.3 Safety PIVC
3.4.7 Parasol Medical
3.4.7.1 Catheter Securement Device
3.4.8 PAVmed Inc.
3.4.8.1 NextCath™
3.4.9 Phase One Medical
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter
3.4.10 Prodigy Diabetes Care, LLC.
3.4.10.1 Insulin Pen Needles
3.4.11 Sharklet Technologies, Inc.
3.4.11.1 Sharklet™ Central Venous Catheter
3.4.12 Starboard Medical
3.4.12.1 Catheter Securement Devices
3.4.13 Teleflex Medical
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System
3.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports
3.4.14 Vascular Access Technologies, Inc.
3.4.14.1 SAFECVAD™
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP Per Capita
4.1.3 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
PERIPHERAL INTRAVENOUS CATHETER MARKET
5.1 INTRODUCTION
5.1.1 Safety PIVCs
5.1.1.1 Blood Control Safety PIVCs
5.1.1.2 Non-Blood Control Safety PIVCs
5.1.1.2.1 Active Safety PIVCs
5.1.1.2.2 Passive Safety PIVCs
5.2 UNIT ANALYSIS
5.2.1.1 Blood Control Safety Peripheral Intravenous Catheter Units Sold by Blood Control Mechanism
5.3 MARKET OVERVIEW
5.4 MARKET ANALYSIS AND FORECAST
5.4.1 Total Peripheral Intravenous Catheter Market
5.4.2 Conventional Peripheral Intravenous Catheter Market
5.4.3 Total Safety Peripheral Intravenous Catheter Market
5.4.3.1 Active Safety Peripheral Intravenous Catheter Market
5.4.3.2 Passive Safety Peripheral Intravenous Catheter Market
5.4.3.3 Integrated Blood Control Safety Peripheral Intravenous Catheter Market
5.4.4 Total Midline Catheter Market
5.4.4.1 Conventional Midline Catheter Market
5.4.4.2 Power-Injectable Midline Catheter Market
5.4.4.3 All-In-One Midline Catheter Market
5.5 DRIVERS AND LIMITERS
5.5.1 Market Drivers
5.5.2 Market Limiters
5.6 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Vascular Access Device and Accessories Market by Segment, Europe, 2013 – 2023
Chart 1 2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023
Chart 4 1: Country Profile, Germany, 2016
Chart 4 2: Country Profile, France, 2016
Chart 4 3: Country Profile, United Kingdom, 2016
Chart 4 4: Country Profile, Italy, 2016
Chart 4 5: Country Profile, Spain, 2016
Chart 4 6: Country Profile, Benelux, 2016
Chart 4 7: Country Profile, Scandinavia, 2016
Chart 4 8: Country Profile, Austria, 2016
Chart 4 9: Country Profile, Switzerland, 2016
Chart 4 10: Country Profile, Portugal, 2016
Chart 5 1: Peripheral Intravenous Catheter Market by Segment, Europe, 2013 – 2023
Chart 5 2: Peripheral Intravenous Catheter Market by Segment, Europe, 2016
Chart 5 3: Peripheral Intravenous Catheter Market by Segment, Europe, 2023
Chart 5 4: Total Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Chart 5 5: Conventional Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Chart 5 6: Total Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Chart 5 7: Active Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Chart 5 8: Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Chart 5 9: Integrated Blood Control Safety Intravenous Catheter Market, Europe, 2013 – 2023
Chart 5 10: Total Midline Catheter Market, Europe, 2013 – 2023
Chart 5 11: Conventional Midline Catheter Market, Europe, 2013 – 2023
Chart 5 12: Power-Injectable Midline Catheter Market, Europe, 2013 – 2023
Chart 5 13: All-In-One Midline Catheter Market, Europe, 2013 – 2023
Chart 5 14: Leading Competitors, Peripheral Intravenous Catheter Market, Europe, 2016
List of Figures
Figure 1 1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (1 of 2)
Figure 1 2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2016
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, Europe, 2016
Figure 1 5: Recent Events in the Vascular Access Device and Accessories Market, Europe, 2013 – 2016
Figure 1 6: Vascular Access Procedures Covered, Europe, 2016
Figure 1 7: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (1 of 3)
Figure 1 8: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (2 of 3)
Figure 1 9: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (3 of 3)
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 3 1: Class 2 Device Recall Medtronic
Figure 3 2: Class 2 Device Recall Smiths Medical
Figure 3 3: Class 2 Device Recall Arrow
Figure 3 4: Class 2 Device Recall Arrow
Figure 3 5: Class 2 Device Recall Covidien (Medtronic)
Figure 3 6: Class 2 Device Recall Arrow
Figure 3 7: Class 2 Device Recall Medline
Figure 3 8: Class 2 Device Recall Arrow
Figure 3 9: Class 2 Device Recall B. Braun
Figure 3 10: Class 3 Device Recall Bard Access
Figure 3 11: Class 2 Device Recall Covidien (Medtronic)
Figure 3 12: Class 2 Device Recall Bard Access
Figure 3 13: Class 2 Device Recall Bard Access
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics
Figure 3 15: Class 2 Device Recall Bard Access
Figure 3 16: Class 2 Device Recall Arrow
Figure 3 17: Class 2 Device Recall Medcomp
Figure 3 18: Class 2 Device Recall Arrow
Figure 3 19: Class 2 Device Recall Arrow
Figure 3 20: Class 2 Device Recall Smiths Medical
Figure 3 21: Class 2 Device Recall PFM Medical
Figure 3 22: Class 2 Device Recall PFM Medical
Figure 3 23: Class 2 Device Recall Becton Dickinson
Figure 3 24: Class 2 Device Recall Arrow
Figure 3 25: Class 2 Device Recall Arrow
Figure 3 26: Class 2 Device Recall Navilyst Medical
Figure 3 27: Class 2 Device Recall Argon Medical
Figure 3 28: Class 2 Device Recall Arrow
Figure 3 29: Class 2 Device Recall Arrow
Figure 3 30: Class 2 Device Recall Arrow
Figure 3 31: Class 2 Device Recall Bard Access
Figure 3 32: Class 2 Device Recall Navilyst Medical
Figure 3 33: Class 2 Device Recall Bard Access
Figure 3 34: Class 2 Device Recall Smiths Medical
Figure 3 35: Class 2 Device Recall B. Braun
Figure 3 36: Class 2 Device Recall Smiths Medical
Figure 3 37: Class 2 Device Recall Access Scientific
Figure 3 38: Class 2 Device Recall Covidien (Medtronic)
Figure 3 39: Class 2 Device Recall Arrow
Figure 3 40: Class 2 Device Recall Bard Access
Figure 3 41: Class 2 Device Recall Becton Dickinson
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 43: Class 2 Device Recall Bard Access
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 45: Class 2 Device Recall Medcomp
Figure 3 46: Class 2 Device Recall Becton Dickinson
Figure 3 47: Class 3 Device Recall Bard Access
Figure 3 48: Class 2 Device Recall Medcomp
Figure 3 49: Class 1 Device Recall Arrow
Figure 3 50: Class 2 Device Recall Arrow
Figure 3 51: Class 2 Device Recall Vygon
Figure 3 52: Class 2 Device Recall Covidien (Medtronic)
Figure 3 53: Class 2 Device Recall Medcomp
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 55: Class 2 Device Recall Christie Medical Holdings
Figure 3 56: Class 3 Recall Bard Access
Figure 3 57: Class 2 Device Recall AngioDynamics
Figure 3 58: Class 2 Device Recall Becton Dickinson
Figure 3 59: Class 2 Device Recall AngioDynamics
Figure 3 60: Class 2 Device Recall AngioDynamics
Figure 3 61: Class 3 Device Recall AngioDynamics
Figure 3 62: Class 2 Device Recall AngioDynamics
Figure 3 63: PICC and Midline Related Complications
Figure 3 64: Contribution of Ultrasound for Peripheral Intravenous Catheter Placement by Intensive Care Nurses
Figure 3 65: A Comparison of Accuvein to Standard Intravenous Access
Figure 3 66: Randomized, Controlled Study of Ultrasound-Guided Peripheral Venous Access
Figure 3 67: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
Figure 3 68: Ultrasound-guided Peripheral Vascular Access in Children
Figure 3 69: Preventing Delay of Care in Patient With Difficult IV Access
Figure 3 70: A Randomized Control Trial of Ultrasound Guided IV Access
Figure 3 71: Removal Peripheral Intravenous Catheters According to Clinical Signs
Figure 3 72: Clinical Investigation Acc. to MPG §23b
Figure 3 73: Evaluation of Accuvein® in Obese Patients
Figure 3 74: A Randomized, Open Label Study to Evaluate the Effectiveness of the MMT Initial Specimen Diversion Device
Figure 3 75: Technique for Successful Ultrasound-guided Peripheral Vascular Access
Figure 3 76: A Randomized Controlled Open Label Trial
Figure 3 77: A Prospective Feasibility Trial of AccuCath® 2.25 BC Intravascular Catheter System
Figure 3 78: The Use of a Topical Anesthetic Skin Refrigerant
Figure 3 79: A Randomized Controlled Trial to Demonstrate the Safety and Efficacy of the OptiVein® IV Catheter
Figure 3 80: Observational Study of the Sonic Window™ Handheld Ultrasound System
Figure 3 81: Near-Infrared Software Performance Study
Figure 3 82: A Randomized Controlled Trial To Compare The Initial Success Rate
Figure 3 83: A Clinical Assessment of an Ultrasound-guided Inserted Peripheral Intravenous Catheter
Figure 3 84: Ultrasound Guided Peripheral Intravenous Catheter Insertion
Figure 3 85: Nurse Peripheral Intravenous Catheter Insertion Success
Figure 5 1: Blood Control Safety Peripheral Intravenous Catheter Units Sold by Blood Control Mechanism, Europe, 2016
Figure 5 2: Peripheral Intravenous Catheter Market by Segment, Europe, 2013 – 2023 (€M)
Figure 5 3: Peripheral Intravenous Catheter Market by Segment, Europe, 2013 – 2023 (US$M)
Figure 5 4: Total Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 5: Units Sold by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Figure 5 6: Average Selling Price by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 7: Average Selling Price by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 8: Market Value by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 9: Market Value by Country, Total Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 10: Conventional Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 11: Units Sold by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Figure 5 12: Average Selling Price by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 13: Average Selling Price by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 14: Market Value by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 15: Market Value by Country, Conventional Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 16: Total Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 17: Units Sold by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Figure 5 18: Average Selling Price by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 19: Average Selling Price by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 20: Market Value by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 21: Market Value by Country, Total Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 22: Active Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 23: Units Sold by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Figure 5 24: Average Selling Price by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 25: Average Selling Price by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 26: Market Value by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 27: Market Value by Country, Active Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 28: Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 29: Units Sold by Country, Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Figure 5 30: Average Selling Price by Country, Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 31: Average Selling Price by Country, Pasive Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 32: Market Value by Country, Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 33: Market Value by Country, Passive Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 34: Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 35: Units Sold by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023
Figure 5 36: Average Selling Price by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€)
Figure 5 37: Average Selling Price by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$)
Figure 5 38: Market Value by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (€M)
Figure 5 39: Market Value by Country, Integrated Blood Control Safety Peripheral Intravenous Catheter Market, Europe, 2013 – 2023 (US$M)
Figure 5 40: Total Midline Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 41: Conventional Midline Catheter Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 42: Power-Injectable Midline Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 43: All-In-One Midline Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 44: Drivers and Limiters, Peripheral Intravenous Catheter Market, Europe, 2016
Figure 5 45: Leading Competitors by Country, Peripheral Intravenous Catheter Market, Europe, 2016
Figure 7 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report